Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 06/30/24). The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare, including 10x Genomics, Relay Therapeutics, Element Biosciences, Inscripta, as well as companies developing next generation therapeutics. Founded in 2011, Foresite Capital is based in San Francisco.
Looking for a particular Foresite Capital employee's phone or email?
Foresite Capital Questions
The Foresite Capital annual revenue was $16.9 million in 2026.
Jim Tananbaum is the Founder and CEO of Foresite Capital.
38 people are employed at Foresite Capital.
Foresite Capital is based in Larkspur, California.
The NAICS codes for Foresite Capital are [52, 523].
The SIC codes for Foresite Capital are [67, 679, 6799].
Top Foresite Capital Employees
-
Jim Tananbaum
Founder and CEO at Foresite Capital
San Francisco, CA, US35 -
Hadi Tabbaa
Managing Director at Foresite Capital
Darien, CT, US21 -
Michael Rome
Managing Director at Foresite Capital
Los Angeles, CA, US24 -
Hyung Chun
Partner at Foresite Capital
New Haven, CT, US45+ -
Stephen Peterson
Partner at Foresite Capital
Denver, CO, US35+ -
Shannon Bergstedt
Director at Foresite Capital
New York, NY, US22 -
Luke Bagaason
Director at Foresite Capital
Denver, CO, US23 -
Rhonda Kaufman
Director at Foresite Capital
Bridgewater, NJ, US15+ -
Jacqueline Guttman
Director at Foresite Capital
New York, NY, US24
Related Companies
